Results of cardiac muscle and skeletal muscle biopsies were compared in 22 patients with cardiomyopathy; 11 patients presented with symptoms secondary to ventricular tachycardia (Group 1) and 11 had symptoms of severe congestive heart failure (Group 2). No patient had structural or ischemic cardiac disease. In Group 1 patients, hemodynamic abnormalities were subtle, but invasive study demonstrated dilated cardiomyopathy in two patients and restrictive cardiomyopathy in nine. In Group 2, eight patients had dilated cardiomyopathy and three had restrictive cardiomyopathy.
Cardiac biopsy results were abnormal in all 22 patients and the abnormalities were similar for the two groups. Cardiac histologic study revealed a spectrum of abnormalities including fibrosis, dilated sarcoplasmic reHistologic abnormalities of cardiac muscle have been previously demonstrated (1) (2) (3) (4) in young patients with congestive heart failure secondary to cardiomyopathy, and similar findings have been reported (5) (6) (7) in young patients presenting with ventricular tachycardia without overt cardiac disease (so called "primary electrical heart disease" ). In most cases the histologic abnormalities are similar (7) . Additionally, histologic abnormalities of skeletal muscle in patients with hemodynamic evidence of cardiomyopathy have been recognized (8, 9) and an association between abnormal skeletal muscle histologic findings and cardiac rhythm disturbances has been previously reported (10) .
ticulum, increased numbers of intercalated discs and mitochondrial abnormalities. Histologic abnormalities of skeletal muscle were similar in each group, consisting of endomysialfibrosisand increased lipid deposits, Slightly more than half of the Group 1 and Group 2 patients also had a low concentration of skeletal muscle long chain acylcarnitine.
These data demonstrate that abnormalities of both cardiac and skeletal muscle are common in patients with cardiomyopathy; abnormalities are similar whether initial symptoms are due to ventricular tachycardia or congestive heart failure. It is suggested that these patients with cardiomyopathy may have a generalized myopathy.
(J Am Coli Cardio/ 1987; 10:608-18) The purpose of this study was to compare cardiac and skeletal muscle histology and biochemistryin young patients whose initial manifestations of cardiac disease were due to symptoms resulting from sustained ventricular tachycardia or congestive heart failure.
Methods
Study patients. Eleven patients (Group I) with ventricular tachycardia or ventricular fibrillation and II patients (Group 2) with symptoms of cardiac failure constituted the study group (Table I ) . All patients underwent invasive and noninvasive cardiac functional evaluation, as well as endomyocardial and skeletal muscle biopsy.
Group I consisted of five male and six female patients, with an average age of 22 years (range IO to 36). Apart from symptoms induced by ventricular arrhythmia, Group I patients were in New York Heart Association functional class I. Symptoms first occurred an average of 16.5 months before study. All Group 1 patients had electrocardiographic (ECG) documentation of ventricular tachycardia (eight patients) or ventricular fibrillation (three patients) before study. No patient had identifiable structural congenital heart disease, ischemic heart disease or neurologic or neuromuscular abnormalities. Group 2 consisted of seven female and four male patients, with an average age of 16 years (range 4 to 39). In contrast to the Group I patients, the II Group 2 patients were evaluated because of severe symptoms of congestive heart failure that had been present for an average of 13 months. These patients were in New York Heart Association class IV and, as part of their evaluation, were being considered for cardiac transplantation. Patient 12 had a history of asthma and Patient 13 had arthrogryposis. No patient had structural congenital heart disease, ischemic heart disease or any clinically apparent neuromuscular or neurologic abnormalities.
Laboratory assessment of hepatic, renal and thyroid function was normal in all patients. Complete blood count and serum electrolytes were also normal.
Clinical observations. A complete history and physical examination were obtained in each patient. A careful review of current and recent drug ingestion was performed. Cardiac evaluation consisted of chest roentgenogram, 12 lead ECG and M-mode and two-dimensional echocardiogram in all patients.
Hemodynamic evaluation. All patients underwent hemodynamic evaluation at cardiac catheterization that consisted of pulmonary artery wedge, pulmonary artery and intracardiac pressure measurements and oximetry. Additionally, in 10patients, ventricular compliance was assessed by repeating hemodynamic measurements after volume administration (10 cc/kg normal saline solution over 5 minutes) (II). Results of these studies were utilized in conjunction with the echocardiographic evaluation to characterize the type of cardiomyopathy present in each patient, based on criteria modified from Goodwin (12) and published normal values ( II , 13, 14) . Our definitions for classification of the type of cardiomyopathy present have been delineated previously (10) . In brief, restrictive cardiomyopathy was defined as normal ventricular size and systolic function, with elevation of ventricular end-diastolic pressures. Dilated cardiomyopathv was defined as abnormal ventricular systolic function with ventricular dilation. Hypertrophic cardiomyopathy was defined as normal or reduced ventricular size with normal ventricular systolic function and increased left ventricular free wall or septal dimension, or both.
Electrophysiologic evaluation. In addition to ambulatory or bedside ECG monitoring, all Group I patients underwent one or more multicatheter electrophysiologic studies. Antiarrhythmic drugs were withheld for > 48 hours before electrophysiologic study. Our previously reported method of evaluation of patients with documented or suspected ventricular tachycardia was employed for all Group I patients (10, 15) . In brief, three quadripolar electrode catheters were inserted through the right femoral vein and positioned in the high right atrium, His bundle regionand right ventricular apex. Stimulation was performed from either the high right atrium or the right ventricular apex using square-wave stimuli of 2 ms duration at twice diastolic current threshold from a custom-made programmable stimulator. Atrioventricular (AV) and ventriculoatrial conduction was assessed using standard techniques (1 6).
To initiate ventricular tachycardia, the f ollowing programmed ventricular stimulation protocol was performed: one to four premature ventricular stimuli were introduced after an eight beat paced train at 600, 500 and 400 ms, and ventricular burst pacing at a cycle length of 400 to 220 ms or to failure of one to one ventricular capture (I5) .
Cardiac muscle evaluation. Right ventricular endomyocardial biopsy was performed in all Group I and Group 2 patients. Four to six biopsy specimens were obtained in each patient. Two or more specimens were inserted into a buffered formalin solution for analysis by light microscopy and two or more specimens were placed in 3% phosphatebuffered glutaraldehyde. Routine light microscopy included hematoxylin-eosin and Masson trichrome staining. For electron microscopy, specimens were postfixed in 220 osmium tetroxide in phosphate buffer, dehydrated in a graded series of alcohol and embedded. Toluidine blue-stained sections were evaluated by light microscopy. Thin sections were stained with uranyl acetate and lead citrate for electron microscopic examination. Cardiac histologic evaluation was performed by one of us (NAS) without knowledgeof specific clinical data.
Skeletal muscle evaluation. After cardiac catheterization, an open skeletal muscle biopsy was obtained in all patients. In a manner described previously (10) , the biopsy specimen was divided for the following studies: I) light microscopy; 2) histochemical analysis; 3) electron microscopy; and 4) carnitine assay. The muscle samples for light microscopic and histochemical analysis were immediately frozen in liquid methylbutane. Subsequently. the biopsy samples were subjected to the following standard stains and reactions (17) : hematoxylin-eosin. modified Gornori-trichrome, phosphorylase A, adenosine triphosphatase at pH 9.4 and. after preincubation at pH 4.55 and 4.75. alphaglycerol phosphate dehydrogenase. reduced diphosphopyridine nucleotide dehydrogenase, succinic dehydrogenase, periodic acid-Schiff, oil red 0 and Sudan black. The muscle samples for electron microscopy were placed immediately in 5% phosphate-buffered glutaraldehyde and. after standard preparation, the grids were stained with uranyl acetate and lead citrate (17) . All histologic and histochemical reactions were reviewed by an observer (S.A.S.) without knowledge of individual patient clinical data.
Carnitine analysis. Fasting serum free carnitine and acylcarnitine (short chain and long chain) were measured by modification of the radioisotopic methods of Pearson et (19) . as previously reported (10) . In these methods, long chain acylcarnitine is separated from free carnitine and short chain acylcarnitine by acid precipitation followed by alkaline extraction. Results were compared with L-carnitine standard solutions by one of us (M.E.P.) without knowledge of individual clinical information.
The muscle biopsv sample/or carnitine and acvlcarnitine determination was immediately frozen in liquid nitrogen. Homogenates were prepared using a Polytron PT-20 (Brinkman Instruments) to homogenize 5 mg/ml (w/vol) of tissue in distilled water. Aliquots were removed for measurement of noncollagenous protein (20) . Samples were assayed for free carnitine, short chain acylcarnitine and long chain acylcarnitine as previously described (10) .
Results
Echocardiographic and hemodynamic evaluation (Table 2). In Group I patients, hemodynamic abnormalities tended to be subtle and in the majority of patients were present only after the fluid challenge. All Group I patients had an inducible ventricular arrhythmia that was electrocardiographically similar to that previously documented. Seven patients had sustained monomorphic ventricular tachycardia, whereas rapid multimorphic ventricular tachycardia was initiated in the three patients who had experienced a cardiac arrest. Patient 8, who had multimorphic ventricular tachycardia documented during a spontaneous syncopal episode, had a similar tachycardia initiated during catheter study. Of the seven patients with monomorphic ventricular tachycardia, the QRS configuration during the tachycardiawas that of right bundle branch block in Patients 3 and 7, whereas Patients 1, 2 and 4 to 6 had a left bundle branch block QRS configuration. The cycle length of monomorphic ventricular tachycardia ranged from 210 to 300 ms (mean 254). Initiated monomorphic ventricular tachycardia was terminated utilizing one to four ventricular extrastimuli interpolated into the tachycardia. Initiated multimorphic ventricular tachycardia was terminated with direct current cardioversion.
Cardiac muscle histologic evaluation ( Table 3) . Cardiac muscle histologic features were abnormal in all patients and the abnormalities were similar in Groups I and 2. In all Group I patients, fibrosis was observed by light microscopy. In Patients 2 and 8, vacuoles were seen by light microscopy and likely represented dilated sarcoplasmic re- Original magnification x 2.000. reduced by 35%. ticulum observed by electron microscopy. Electron microscopic evaluation of the endomyocardial biopsy frequently demonstrated additional abnormalities within myocardial cells, including increased lipid droplets in six patients, dilated sarcoplasmic reticulum in seven, mitochondrial abnormalities in four and increased numbers of intercalated discs in four ( Fig. I and 2) .
In Group 2, cardiac histologic evaluation demonstrated abnormalities that were quite similar to those seen in Group I. Fibrosis was present by light microscopic evaluation in all II Group 2 patients and Patients 12 and 17 had vacuoles observed by light microscopy that likely represented dilated sarcoplasmic reticulum observed by electron microscopy. Additional intracellular electron microscopic abnormalities included increased numbers of irregular intercalated discs in six patients, dilated sarcoplasmic reticulum in four patients, Z-band streaming in three patients and myofibrillar loss in two patients (Fig. 3 and 4) . Thus, on the basis of cardiac biopsy. the two patient groups could not be differentiated.
Skeletalmuscle histologic evaluation (Table 4) . In Group I. skeletal muscle histologic features were normal by light microscopic and histochemical evaluation in Patients 3, 6 and 8, but were normal on electron microscopic study only in Patient 6. The principal abnormalities included increased quantities of lipid in type I muscle fibers (eight patients) and endomysial fibrosis (eight patients) (Fig. 5 and 6 ). Nonspecific myopathic features, consisting of type" fiber hypotrophy, were seen in Patient 3. By electron microscopy, Patient 7 also had subsarcolemmal mitochondrial aggregates.
The results of skeletal muscle histologic evaluation were similar for the Group I and Group 2 patients. In Group 2. only Patient 15 had normal skeletal muscle by light micro- scopic and histochemical evaluation; Patient 15 also had a normal electron microscopic skeletal muscle evaluation. The principal skeletal muscle abnormalities in Group 2 patients were increased quantities of lipid in type I muscle fibers (nine patients), endomysial fibrosis (six patients) and type II fiber hypotrophy with or without fibersize variation(eight patients) ( Fig. 7 and 8) . Additionally , Patient 13 had variably shaped mitochondria and subsarcolemmal mitochondrial aggregates observed by electron microscopy. Carnitine analysis (Table 5) . No abnormalities were detected in any patient in fasting serum free camitine or short and long chain acylcamitine concentrations. Skeletal muscle camitine determinations were also similar for the two patient groups (Table 5) . One patient in each group, Patients 9 and 16, had a low concentration « 10 nmollmg of noncollagenous protein) of skeletal musclefree camitine. However, 7 of 11 Group I patients (Patients 1,2,5,6,9, I0 and II ) and 6 of II Group2 patients (Patients 14,16,17,1 8.19 and 21 ) had a low skeletal muscle concentration of long chain acylcamitine.
Discussion
Cardiac and skeletal myopathy. The principal finding s of our study are that young patients with cardiomyopathy who develop either ventricular tachycardia or congestive heart failure have histologic abnormalities of skeletal and cardiac muscle; further, cardiac and skeletal muscle histologic features do not permit differentiation of these two groups of patients. Abnormalities of both cardiac and skeletal muscle suggest the presence of a generalized myopathy in both groups of patients. The cause of the generalized myopathy is not known. However, the possibility that an abnormality of muscle metabolism is responsible is supported by the frequent finding of low concentrations of long chain acylcarnitine in skeletal muscle in both groups of patients.
It is possible that the underlying myopathic process is similar in both groups of patients and that the clinical manifestation of the disease may be related to factors other than a specific disease process. For example, Patient I presented with ventricular tachycardia, but over the ensuing 30 months, subsequently developed severe congestive heart failure necessitating cardiac transplantation.-T hus;-i f -patients presenting with rhythm disturbances as the initial manifestation of myopathy live long enough, signs and symptoms of poor mechanicalcardiac function may develop. The converse has been well recognized in that patients with congestive heart failure due to dilated cardiomyopathy frequently develop ventricular tachycardia (21) (22) (23) (24) . In fact, in some cases these However. the occurrence of ventricular tachycardia in this setting has generally been thought to be secondary to the hemodynamic abnormalities. On the other hand. our patients with ventricular tachycardia had only subtle findings of hemodynamic dysfunction, but no clinical symptoms of congestive heart failure. Thus, in this group of patients (Group I) it does not seem that the tachycardia is necessarily secondary to abnormal hemodynamics.
Cardiac muscle abnormalities. Previous reports (1-3) have described cardiac histologic abnormalities in patients with cardiomyopathy, including some patients with heart failure symptoms in whom the diagnosis of myocarditis was established from the biopsy (3, 4, 25, 26) . No patient in our study had myocarditis or acute round cell cardiac infiltrate. The young patients with ventricular tachycardia that we studied all had cardiac histologic abnormalities, and most had subtle hemodynamic abnormalities as well. It is possible that all patients with ventricular tachycardia have myocardial dysfunction, but that conventional methods for functional evaluation are not sensitive enough to detect abnormalities in everyone. From the histologic and biochemical studies in these ostensibly healthy young patients with ventricular arrhythmias, it is now apparent that the extent of heart disease is belied by the normalcy of physical and laboratory evaluation of cardiac status. Thus we question use of the term ' .primary electrical disease."
A major limitation in several previous reports (5) (6) (7) describing cardiac biopsy results in patients with rhythm disturbances but without structural heart disease is that they have been obtained at only one instant in what may be a progressive disease or a disease subject to exacerbations or quiescent periods. In contrast. Cassling et al. (27) reported sequential biopsies in two patients with prebiopsy diagnoses of myocarditis. One patient appeared to develop interstitial fibrosis over the 6 week period between biopsies, whereas in the other patient, initial abnormalities appeared to decrease between biopsies. Thus, the natural history of idio- pathic cardiomyopathy may be enlightened with serial cardiac biopsies.
It is important to note that our patients with congestive heart failure symptoms had myocardial histologic abnormalities that were similar to those seen in patients whose clinical symptoms were secondary to ventricular tachycar- dia. The findings of interstitial fibrosis, dilated sarcoplasmic reticulum, increased numbers of intercalated discs and increased lipid are definitely abnormal, but nonspecific. They were similar for both groups of patients. Skeletal muscle abnormalities. Two aspects of the skeletal muscle evaluation deserve additional comment. First, the histologic abnormalities in skeletal muscle were similar for the patients with ventricular tachycardia and those with congestive heart failure. Because the patients with tachycardia were completely asymptomatic when the arrhythmia was absent, skeletal muscle abnormalities were unlikely to be secondary to cardiac hemodynamic dysfunction. Second, the findings of skeletal muscle histologic abnormalities and low concentrations of skeletal muscle long chain acylcarnitine in these patients seem more than coincidental. No patient in our study had systemic camitine deficiency; patients with carnitine deficiency usually have massive accumulations of lipid in skeletal muscle (28) . Skeletal muscle histologic abnormalities similar to those found in our patients have been described in patients with normal or only mildly decreased skeletal muscle camitine concentrations (29) , and in patients with normal skeletal muscle carnitine but with carnitine-palmityl-transferase deficiency (30) . Thus, the abnormalities of increased lipid deposition and reduced long chain acylcamitine concentrations in skeletal muscle are not specific for a single biochemical or metabolic defect, but together these findings suggest that a disorder of fatty acid metabolism is present.
Coexistent cardiac and skeletal myopathy. Few reports (8-10) have linked skeletal muscle histologic abnormalities to cardiomyopathy, in which presenting symptoms are secondary to either cardiac electrical (ventricular tachycardia) or mechanical (congestive heart failure) dysfunction. In contrast, it is well recognized that patients with various neuromuscular diseases may also have cardiac muscle involvement (31) (32) (33) (34) (35) (36) (37) . The clinical manifestations of such involvement may be a result of rhythm disturbances or heart failure, but generally appear late in the course of disease after the diagnosis of the peripheral muscle disease is well established. In contrast to other patients with neuromuscular disease, the primary clinical manifestation of our patients involved symptoms secondary to ventricular tachycardia or congestive heart failure, with the peripheral muscle involvement being subclinical.
